Navigation Links
Peaceful Slumber said to Restore Memories

d. "This takes it to a new level."

For example, he said the people trained late at night may have performed better because they went to sleep not long after their training, while their morning trained counterparts were exposed to an entire day of memories before being tested.

In that study, one group was trained at 9 a.m., then tested 12 hours later, while a second group was trained at 9 p.m. and then tested the next morning after a night's sleep. The researchers found that while the people tested at night experienced a 10 percentage point improvement over their pre-training test, those who had a night's sleep had a 19 percentage point improvement over their pre-training test.

In the second study, Harvard Medical School scientists trained 100 subjects ages 18-27 to perform finger-tapping sequences similar to learning piano scales. Their ability to repeat those sequences was then tested at various intervals, including after one and two nights of sleep. The researchers found evidence that memories are consolidated in three stages in a process similar to storing data on a computer's hard drive. The second stage requires sleep, which the Harvard team also found sharpened the subject's performance the next day.

However, when subjects briefly rehearsed a finger-tapping sequence they had learned the previous day just before learning a second exercise, their accuracy on the first sequence suffered when they tried to repeat it on the third day.

But they performed the second exercise reliably -- suggesting that "not all memories are equal," and the order in which they are learned may be important . Researchers thus concluded that further experiments are needed to assess a number of factors that could have influenced the outcomes.
'"/>




Page: 1 2

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. Vitamin E Could Restore Sudden Hearing Loss
3. Running Water Restored In Chinese City
4. Silicone Rubber Flap Restore Speech
5. Restore Ban on Weight Loss Aid, Ephedra – FD
6. Gene Therapy May Help Restore Sight In Congenital blindness
7. Blood Flow to Kidneys Better Restored by Less Invasive Procedures
8. Stress Therapy can Restore Fertility: Study
9. Minimally Invasive Procedure Restores Sagging Facial Skin without Heavy Lifting
10. Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice
11. Research Extraordinaire To Restore Vision
Post Your Comments:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6New Robotic Arm Has Softer Surgical Touch 55753 1New Robotic Arm Has Softer Surgical Touch 55753 2Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 1Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 2Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 3Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 1Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 2Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 3
Other Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 5Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 6Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 7Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 8Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 9Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 10Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 11Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2